Investigating Antidepressants’ Surprising Effect on COVID Deaths

View Content

Another article describing Andrea Fekete and Eric Lenses findings on fluvoxamine’s efficacy against fighting the worst of the COVID symptoms. The article describes the way fluvoxamine allows for the body’s inflammatory system to keep in check due to the presence of the sigma-1 receptor.

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *